trending Market Intelligence /marketintelligence/en/news-insights/trending/lT3AalfNb6hbNld5PP9SbQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Australia's Respiri completes A$3.2M placement

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Australia's Respiri completes A$3.2M placement

Australia's Respiri Ltd. completed its private placement of 39,375,000 ordinary shares at 8 Australian cents per share for gross proceeds of A$3.2 million.

Trading of the shares issued under the sale will occur on Dec. 27.

Respiri previously said the capital raising provides the company with the financial capability to produce and launch its wheezo product in early 2019. Wheezo is a device for managing asthma that also comes with a companion mobile application.

Fawkner Capital Management Pty. Ltd. acted as lead manager for the placement.